Toxicity of long-term use of proton pump inhibitors in children.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29237614.
- Also identified by DOI 10.1136/archdischild-2017-314026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Proton pump inhibitor (PPI) use is becoming increasingly common. Although the toxicity profiles of PPIs are not well understood particularly in children, PPIs have been associated with increased risks of gastrointestinal and respiratory tract infection, vitamin B<sub>12</sub> deficiency, hypomagnesaemia, bone fractures, and rebound hyperacidity after discontinuation. Prescribers should take into account that PPI uses pose toxicity risks, which remain to be fully characterised in infants and children.
Medical subject headings
- Gastroesophageal Reflux
- Proton Pump Inhibitors